Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Airway tissue mast cells in persistent asthma: predictor of treatment failure when patients discontinue inhaled corticosteroids.

Kraft M, Martin RJ, Lazarus SC, Fahy JV, Boushey HA, Lemanske RF Jr, Szefler SJ; Asthma Clinical Research Network.

Chest. 2003 Jul;124(1):42-50.

PMID:
12853500
2.

Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial.

Lazarus SC, Boushey HA, Fahy JV, Chinchilli VM, Lemanske RF Jr, Sorkness CA, Kraft M, Fish JE, Peters SP, Craig T, Drazen JM, Ford JG, Israel E, Martin RJ, Mauger EA, Nachman SA, Spahn JD, Szefler SJ; Asthma Clinical Research Network for the National Heart, Lung, and Blood Institute.

JAMA. 2001 May 23-30;285(20):2583-93.

PMID:
11368732
3.

Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial.

Lemanske RF Jr, Sorkness CA, Mauger EA, Lazarus SC, Boushey HA, Fahy JV, Drazen JM, Chinchilli VM, Craig T, Fish JE, Ford JG, Israel E, Kraft M, Martin RJ, Nachman SA, Peters SP, Spahn JD, Szefler SJ; Asthma Clinical Research Network for the National Heart, Lung, and Blood Institute.

JAMA. 2001 May 23-30;285(20):2594-603.

PMID:
11368733
4.

The effect of salmeterol on nocturnal symptoms, airway function, and inflammation in asthma.

Kraft M, Wenzel SE, Bettinger CM, Martin RJ.

Chest. 1997 May;111(5):1249-54.

PMID:
9149578
5.

An antiinflammatory effect of salmeterol, a long-acting beta(2) agonist, assessed in airway biopsies and bronchoalveolar lavage in asthma.

Li X, Ward C, Thien F, Bish R, Bamford T, Bao X, Bailey M, Wilson JW, Haydn Walters E.

Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 1):1493-9.

PMID:
10556111
6.

The long-acting beta2-agonist salmeterol xinafoate: effects on airway inflammation in asthma.

Roberts JA, Bradding P, Britten KM, Walls AF, Wilson S, Gratziou C, Holgate ST, Howarth PH.

Eur Respir J. 1999 Aug;14(2):275-82.

7.

Anti-inflammatory effects of salmeterol compared with beclomethasone in eosinophilic mild exacerbations of asthma: a randomized, placebo controlled trial.

Turner MO, Johnston PR, Pizzichini E, Pizzichini MM, Hussack PA, Hargreave FE.

Can Respir J. 1998 Jul-Aug;5(4):261-8.

PMID:
9753527
8.

Possible anti-inflammatory effect of salmeterol against interleukin-8 and neutrophil activation in asthma in vivo.

Reid DW, Ward C, Wang N, Zheng L, Bish R, Orsida B, Walters EH.

Eur Respir J. 2003 Jun;21(6):994-9.

9.

Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids.

Wilson AM, Dempsey OJ, Sims EJ, Lipworth BJ.

Chest. 2001 Apr;119(4):1021-6.

PMID:
11296164
10.

Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma.

Ward C, Pais M, Bish R, Reid D, Feltis B, Johns D, Walters EH.

Thorax. 2002 Apr;57(4):309-16.

11.

Benefit from anti-inflammatory treatment during clinical remission of atopic asthma.

van den Toorn LM, Prins JB, de Jongste JC, Leman K, Mulder PG, Hoogsteden HC, Overbeek SE.

Respir Med. 2005 Jun;99(6):779-87. Epub 2005 Jan 12.

12.
13.

Effect of a long-acting beta2-agonist over three months on airway wall vascular remodeling in asthma.

Orsida BE, Ward C, Li X, Bish R, Wilson JW, Thien F, Walters EH.

Am J Respir Crit Care Med. 2001 Jul 1;164(1):117-21.

PMID:
11435249
14.
16.

The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol.

Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM; SMART Study Group.

Chest. 2006 Jan;129(1):15-26. Erratum in: Chest. 2006 May;129(5):1393.

PMID:
16424409
17.

Effect of inhaled fluticasone with and without salmeterol on airway inflammation in asthma.

Wallin A, Sue-Chu M, Bjermer L, Ward J, Sandström T, Lindberg A, Lundbäck B, Djukanović R, Holgate S, Wilson S.

J Allergy Clin Immunol. 2003 Jul;112(1):72-8.

PMID:
12847482
18.

Salmeterol decreases eosinophilic cationic protein and rescue medication in patients inhaling beclomethasone dipropionate: preliminary study in mild and moderate asthma in Trinidad, West Indies.

Pinto Pereira LM, Clement Y, Rouse J, Matthew J, Asgarali Z, Ramoutar D, Teelucksingh S.

Int J Clin Pharmacol Res. 2003;23(2-3):69-74.

PMID:
15025036
20.

Control of airway inflammation maintained at a lower steroid dose with 100/50 microg of fluticasone propionate/salmeterol.

Jarjour NN, Wilson SJ, Koenig SM, Laviolette M, Moore WC, Davis WB, Doherty DE, Hamid Q, Israel E, Kavuru MS, Ramsdell JW, Tashkin DP, Reilly DS, Yancey SW, Edwards LD, Stauffer JL, Dorinsky PM, Djukanovic R.

J Allergy Clin Immunol. 2006 Jul;118(1):44-52. Epub 2006 Jun 2.

PMID:
16815137

Supplemental Content

Support Center